Vaxart, Inc. (VXRT)
NASDAQ: VXRT · IEX Real-Time Price · USD
0.675
-0.009 (-1.26%)
At close: Jul 19, 2024, 4:00 PM
0.673
-0.002 (-0.30%)
Pre-market: Jul 22, 2024, 7:27 AM EDT
Vaxart Market Cap
Vaxart has a market cap or net worth of $153.51 million as of July 22, 2024. Its market cap has increased by 56.97% in one year.
Market Cap
153.51M
Enterprise Value
136.34M
1-Year Change
56.97%
Ranking
Category
Stock Price
$0.68
Market Cap Chart
Since December 1, 1998, Vaxart's market cap has increased from $89.40M to $153.51M, an increase of 71.71%. That is a compound annual growth rate of 2.13%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 19, 2024 | 119.40M | 37.08% |
Dec 29, 2023 | 87.10M | -30.93% |
Dec 30, 2022 | 126.10M | -83.98% |
Dec 31, 2021 | 786.90M | 25.88% |
Dec 31, 2020 | 625.10M | 3,643.11% |
Dec 31, 2019 | 16.70M | 24.63% |
Dec 31, 2018 | 13.40M | -38.81% |
Dec 29, 2017 | 21.90M | -53.89% |
Dec 30, 2016 | 47.50M | -36.67% |
Dec 31, 2015 | 75.00M | -4.58% |
Dec 31, 2014 | 78.60M | -33.84% |
Dec 31, 2013 | 118.80M | 531.91% |
Dec 31, 2012 | 18.80M | -76.67% |
Dec 30, 2011 | 80.60M | -67.21% |
Dec 31, 2010 | 245.80M | -1.17% |
Dec 31, 2009 | 248.70M | 42.93% |
Dec 31, 2008 | 174.00M | -21.20% |
Dec 31, 2007 | 220.80M | -46.13% |
Dec 29, 2006 | 409.90M | 104.24% |
Dec 30, 2005 | 200.70M | -76.55% |
Dec 31, 2004 | 855.90M | 44.31% |
Dec 31, 2003 | 593.10M | 147.13% |
Dec 31, 2002 | 240.00M | -38.92% |
Dec 31, 2001 | 392.90M | 125.03% |
Dec 29, 2000 | 174.60M | 7.98% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Achieve Life Sciences | 159.00M |
Context Therapeutics | 159.00M |
Assertio Holdings | 156.00M |
Rani Therapeutics Holdings | 155.29M |
OptiNose | 153.53M |
Kodiak Sciences | 150.78M |
High Tide | 150.43M |
Galectin Therapeutics | 150.40M |